EU Regulator Authorizes AstraZeneca Vaccine for All Adults

A vial of the COVID-19 vaccine developed by Oxford University and UK-based drugmaker AstraZeneca is checked as they arrive at the Princess Royal Hospital in Haywards Heath, England, on Jan. 2, 2021. Gareth Fuller/Pool via AP

BERLIN—Regulators authorized AstraZeneca’s coronavirus vaccine for use in adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population.

A general view of AstraZeneca offices and the corporate logo in Cambridge, England, on July 18, 2020.  Alastair Grant/AP Photo